Resource Links

Status	Official Title	Lead Investigator	Last Updated
Finalised	Characterising the risk of major bleeding in patients with Non-Valvular Atrial Fibrillation: non-interventional study of patients taking Direct Oral Anticoagulants in the EU	Dr Helga Gardarsdottir	09/11/2020
Finalised	Atrial fibrillation and heart failure associated to gabapentin and pregabalin	Professor Joan-Ramon Laporte	13/02/2019
Ongoing	The European Drug-induced Agranulocytosis Consortium Study	Dr Pär Hallberg	18/12/2013
Ongoing	CHARACTERISATION OF PROTEOMIC PROFILES PREDICTIVE OF HEPATOTOXICITY ASSOCIATED WITH ANTI-TUBERCULOSIS DRUGS: A PILOT STUDY	Dr Luisa Ibáñez	29/10/2010
Planned	Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines	Dr Caitlin Dodd	22/09/2020
Planned	Use of antidepressant drugs and its association with risk of stroke, frequency of hospitalization, and mortality in an elderly population: a descriptive and analytic cohort study	Dr Luisa Ibañez	01/06/2017
Planned	Assessment of cardiovascular effects of non-insulin glucose-lowering agents. Major cardiovascular events in new users of non-insulin glucose-lowering agents: observational longitudinal study in the Catalan population-based electronic health record database, SIDIAP, 2010-2015	Dr Xavier Vidal	06/04/2017
Planned	RISK OF AGRANULOCYTOSIS ASSOCIATED WITH THE USE OF DRUGS	Professor Joan-Ramon Laporte	03/09/2015